Statement attributed to:

David O. Barbe, M.D.

President, American Medical Association

“The AMA is pleased the Trump administration is moving forward with its effort to address seemingly arbitrary pricing for prescription drugs. Physicians see the impact of skyrocketing prices every day as patients are often unable to afford the most medically appropriate medications — even those that have effectively controlled their medical condition for years.

“No one can understand the logic behind the high and fluctuating prices. We hope the administration can bring some transparency — and relief — to patients.”

Media Contact:

Jack Deutsch

ph: (202) 789-7442

[email protected]

About the American Medical Association

The American Medical Association is the physicians’ powerful ally in patient care. As the only medical association that convenes 190+ state and specialty medical societies and other critical stakeholders, the AMA represents physicians with a unified voice to all key players in health care.  The AMA leverages its strength by removing the obstacles that interfere with patient care, leading the charge to prevent chronic disease and confront public health crises and, driving the future of medicine to tackle the biggest challenges in health care.

FEATURED STORIES